Skip to main content
Completed Clinical Trials

Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

By April 24, 2017No Comments

Condition

Advanced Malignant Mesothelioma|Carcinoma of the Appendix|Ovarian Sarcoma|Ovarian Stromal Cancer|Pseudomyxoma Peritonei|Recurrent Colon Cancer|Recurrent Malignant Mesothelioma|Recurrent Ovarian Epithelial Cancer|Recurrent Ovarian Germ Cell Tumor|Stage III Colon Cancer|Stage III Ovarian Epithelial Cancer|Stage III Ovarian Germ Cell Tumor|Stage IV Colon Cancer|Stage IV Ovarian Epithelial Cancer|Stage IV Ovarian Germ Cell Tumor|Unspecified Childhood Solid Tumor, Protocol Specific

Estimated Enrollment: 10

Age Group: Child, Adult, Senior

Gender: All

Study Type: Interventional

Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Supportive Care

Study ID Numbers: CCCWFU 97110|NCI-2010-00980

Study First Received: May 13, 2010

Last Updated: January 17, 2017

Estimated Primary Completion Date: April 2011

 

Primary Outcome Measures:

Assess feasibility of instituting an orientation program, brief follow up care and phone calls in this patient population|Reduce pre-treatment distress and anxiety|Improve pre-treatment self-efficacy|Provide educational material delivered by the SRB|Improve overall post-operative QOL ratings at 3 months, relative to discharge

Sponsors and Collaborators:

Wake Forest University Health Sciences

Website Link: https://ClinicalTrials.gov/show/NCT01126346

Leave a Reply